WAVE LIFE SCIENCES LTD. Increase (Decrease) in Other Noncurrent Assets
WAVE LIFE SCIENCES LTD. (WVE) reported Increase (Decrease) in Other Noncurrent Assets of $7.47 million for the 9-month period ending 2019-09-30, per its 10-Q filed 2019-11-05.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherNoncurrentAssets · last filed 2019-11-05
- WAVE LIFE SCIENCES LTD. increase (decrease) in other noncurrent assets for the quarter ending 2019-09-30 was $2.56M, a 51120.00% increase year-over-year.
- WAVE LIFE SCIENCES LTD. increase (decrease) in other noncurrent assets for the quarter ending 2019-06-30 was $2.33M.
- WAVE LIFE SCIENCES LTD. increase (decrease) in other noncurrent assets for the quarter ending 2019-03-31 was $2.58M, a 23327.27% increase year-over-year.
- WAVE LIFE SCIENCES LTD. increase (decrease) in other noncurrent assets for the quarter ending 2018-09-30 was $5.00K.
- WAVE LIFE SCIENCES LTD. increase (decrease) in other noncurrent assets for fiscal 2017 was $358.00K.
| Period end | Increase (Decrease) in Other Noncurrent Assets 3 month | Increase (Decrease) in Other Noncurrent Assets 6 month | Increase (Decrease) in Other Noncurrent Assets 9 month | Increase (Decrease) in Other Noncurrent Assets 12 month |
|---|---|---|---|---|
| 2019-09-30 | $2.56M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | $4.89M derived: sum of 2 quarters · filed 2019-11-05 | $7.47M 10-Q · filed 2019-11-05 | |
| 2019-06-30 | $2.33M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | $4.91M 10-Q · filed 2019-08-06 | ||
| 2019-03-31 | $2.58M 10-Q · filed 2019-05-10 | |||
| 2018-09-30 | $5.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | $4.00K derived: sum of 2 quarters · filed 2019-11-05 | $15.00K 10-Q · filed 2019-11-05 | $366.00K derived: sum of 4 quarters · filed 2019-11-05 |
| 2018-06-30 | -$1.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | $10.00K 10-Q · filed 2019-08-06 | $361.00K derived: sum of 3 quarters · filed 2019-08-06 | |
| 2018-03-31 | $11.00K 10-Q · filed 2019-05-10 | $362.00K derived: sum of 2 quarters · filed 2019-05-10 | ||
| 2017-12-31 | $351.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-12 | $358.00K 10-K · filed 2018-03-12 | ||
| 2017-09-30 | $7.00K 10-Q · filed 2018-11-09 | |||
| 2016-09-30 | $53.00K 10-Q · filed 2017-11-09 | |||
| 2016-03-31 | $53.00K 10-Q · filed 2017-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |